4//SEC Filing
Protalix BioTherapeutics, Inc. 4
Accession 0001144204-15-070834
$PLXCIK 0001006281operating
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 7:30 AM ET
Size
6.6 KB
Accession
0001144204-15-070834
Insider Transaction Report
Form 4
Maimon Yossi
VP, Chief Financial Officer
Transactions
- Purchase
Common Stock
2015-12-14$0.78/sh+10,000$7,800→ 10,000 total
Holdings
- 185,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., issued under its 2006 Stock Incentive Plan, as amended June 17, 2012 (the "Plan"). The restricted shares vest in 16 equal quarterly increments over a four-year period, commencing on the date of grant. In addition to the vesting period, vested restricted shares will be subject to a lock-up for a 24-month period commencing upon the vesting date. Notwithstanding the foregoing and subject to certain exceptions, the vesting period will accelerate immediately upon a Change in Control or Corporate Transaction, each as defined in the Plan, and the lock-up periods will terminate.
- [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001006281
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 7:30 AM ET
- Size
- 6.6 KB